|
|
|
|
|
by phobosanomaly
2028 days ago
|
|
Both Moderna and Pfizer trials have secondary outcomes that are measurable, protective, neutralizing antibody titers. Check out the Pfizer press release. The vaccine is eliciting robust SARS-CoV-2 neutralizing antibodies, as well as T-cell responses. https://www.pfizer.com/news/press-release/press-release-deta... That's a direct mechanism of protection that will help to both prevent people from getting sick, and knock down shedding. You're getting so far off in the details that you're missing the forest for the trees. |
|
That's what the reported numbers claim: up to 95% people less are getting sick.
But it's unknown how much it will "knock down shedding" and the experts who follow only publicly available data are still cautious to claim the opposite of what you claim, specifically:
"it will be important to communicate to policy makers and the general public that first-generation vaccines are only one tool in the overall public health response to COVID-19 and unlikely to be the ultimate solution that many expect."
You may not like that or believe something else, but it's not what I hear and read the mentioned experts say, like, as an example, Natalie E. Dean whose article I've already linked to, and you can follow her other writings too. And, as far as I know, her opinion is far from being untypical, i.e. it would be easy to find more actual experts (which I define as those who were doing active research even before Covid-19 in the field and not something totally unrelated and who aren't just jumping in for political purposes -- note that that definition automatically excludes those like Ioannidis) who publicly say the same.